Welcome to our dedicated page for Teradyne SEC filings (Ticker: TER), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Teradyne’s filings can feel like a maze of wafer-probe yields, robot backlog figures and segment margin footnotes. If you have ever tried to extract robotics revenue trends or find when executives exercised stock options inside a 300-page report, you know the challenge. Our platform tackles that complexity head-on, turning every Teradyne annual report 10-K simplified and each Teradyne quarterly earnings report 10-Q filing into clear, searchable insights.
Stock Titan’s AI reads each document the moment it hits EDGAR and delivers:
- Teradyne Form 4 insider transactions real-time, so you monitor executive stock moves without waiting.
- Concise notes that make Teradyne 8-K material events explained in plain English.
- Segment breakouts and cash-flow flags highlighted inside every Teradyne earnings report filing analysis.
- Red-lined changes across proxies for quick views of Teradyne proxy statement executive compensation shifts.
Whether you’re understanding Teradyne SEC documents with AI for long-term research or need instant alerts on Teradyne insider trading Form 4 transactions, our coverage spans all forms—10-K, 10-Q, 8-K, S-8 and more. Investors routinely use these insights to compare semiconductor test bookings quarter over quarter, gauge robotics margin expansion, and track Teradyne executive stock transactions Form 4 before earnings. Teradyne SEC filings explained simply mean no more scrolling past dense test-equipment jargon: just the numbers, risks and material disclosures that move the stock.
Teradyne, Inc.'s President and CEO, who is also a director, reported a sale of common stock. On December 12, 2025, the insider sold 1,108 shares of Teradyne common stock at $ 201.31 per share, coded as a sale transaction.
The shares were sold pursuant to a sales plan adopted by the reporting person on February 4, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. After this transaction, the insider beneficially owned 93,408.995 shares of Teradyne common stock, held directly.
Teradyne, Inc. (TER) reported an insider transaction: the President and CEO, who is also a Director, sold 1,108 shares of common stock on 11/12/2025 at a price of $180.2 per share, coded as S (sale). The filing notes the sale was made under a Rule 10b5-1 trading plan adopted on 02/04/2025.
Following this transaction, the reporting person beneficially owns 94,516.995 shares, held directly.
Teradyne (TER) reported an insider equity transaction by its President and CEO, who is also a director. On November 5, 2025, the executive exercised a stock option for 2,072 shares at an exercise price of $36.75 (code M).
To cover the option exercise price and associated tax withholding, the issuer withheld 1,224 shares at a price of $177.05 (code F), as noted in the footnotes. Following these transactions, the reporting person beneficially owned 95,624.995 shares, held directly.
The option referenced vested 25% per year over four years beginning January 25, 2020.
Teradyne (TER): Form 4 insider transaction — A director reported a sale of common stock. On 11/05/2025, the reporting person sold 625 shares at $177.05 per share under a pre-arranged Rule 10b5-1 trading plan adopted on February 3, 2025.
Following the transaction, the reporting person beneficially owned 9,488 shares directly. In addition, 1,876 shares were held indirectly by The Mercedes Johnson Trust UAD 07/23/04, for which the reporting person serves as trustee and sole beneficiary.
Teradyne, Inc. (TER) reported insider equity awards to its Chief Financial Officer on 11/03/2025. The filing shows a grant of 11,144 restricted stock units (RSUs) at $0, and a stock option to buy 9,156 shares with a $183.07 exercise price.
The RSUs vest in four equal annual installments beginning on November 3, 2026. The option vests 25% per year over four years beginning on November 3, 2026, and expires on November 3, 2032. Following the transactions, the officer beneficially owned 11,260 shares of common stock directly.
Teradyne, Inc. (TER) reported an initial insider ownership filing. On 11/03/2025, the company’s Chief Financial Officer filed a Form 3, disclosing beneficial ownership of 116 shares of common stock, held directly. No derivative securities were reported. This filing establishes the officer’s baseline holdings under Section 16 reporting rules.
Teradyne filed its Q3 2025 10‑Q, reporting modest revenue growth with lower profitability. For the quarter ended September 28, 2025, total revenues were $769.2 million versus $737.3 million a year ago, driven mainly by Semiconductor Test $440.2 million, Product Test $88.3 million, and Robotics $75.1 million. Asia Pacific accounted for $612.8 million of quarterly revenue. Gross profit was $449.3 million.
Operating income was $145.3 million and net income was $119.6 million (diluted EPS $0.75) compared with $145.6 million (EPS $0.89) last year, reflecting higher operating expenses and a $5.2 million loss from equity in net earnings of affiliate. Year‑to‑date, revenue was $2.11 billion with net income of $296.8 million.
Cash from operations for the nine months was $392.8 million. The company repurchased $523.8 million of stock and paid $57.6 million in dividends ($0.36 per share) year‑to‑date. Cash and cash equivalents were $272.7 million with $200.0 million of short‑term debt. Teradyne completed the $127.2 million acquisition of Quantifi Photonics and a $18.3 million automated test equipment technology acquisition. Unsatisfied performance obligations were $1,744.4 million, with about 89% expected within 12 months.
Teradyne (TER) appointed Michelle Turner as Vice President, Chief Financial Officer, and Treasurer, effective November 3, 2025. She will serve as principal financial officer and principal accounting officer. Sanjay Mehta will remain as an executive advisor with compensation unchanged.
Turner’s compensation includes a $640,000 annual base salary and an annual cash incentive bonus with a target equal to 100% of base salary. On November 3, 2025, she will receive an equity award valued at $6,800,000 at target, comprising time-based RSUs, performance-based RSUs, and non-qualified stock options. One-time cash payments include a $200,000 sign-on bonus and $150,000 for relocation.
Her change-of-control agreement provides two years of severance at the annual Model Compensation rate, a prorated target bonus for the year of termination, full accelerated vesting of equity awards (performance awards at target), and two years of continued health, dental, and vision coverage, without a tax gross-up.
Teradyne (TER) reported an insider transaction by its President and CEO (also a Director). On October 10, 2025, the executive sold 1,108 shares of common stock at $145.24 per share. Following the sale, the executive beneficially owns 94,776.995 shares, held directly. The sale was made under a pre‑established Rule 10b5‑1 trading plan adopted on February 4, 2025.
FAQ
What is the current stock price of Teradyne (TER)?
What is the market cap of Teradyne (TER)?
